Groupama Asset Managment »

Jazz Pharmaceuticals shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.2M 67k 123.04

More positions owned by Groupama Asset Managment

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
UnitedHealth (UNH)
NVIDIA Corporation (NVDA)
Motorola Solutions Com New (MSI)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Parker-Hannifin Corporation (PH)
Thermo Fisher Scientific (TMO)
Regeneron Pharmaceuticals (REGN)
Tesla Motors (TSLA)

View all positions for Groupama Asset Managment

Top funds holding Jazz Pharmaceuticals

BlackRock
Vanguard Group
LSV Asset Management
Jpmorgan Chase & Co
Polaris Capital Management
Pacer Advisors
Wellington Management Company
EcoR1 Capital
Franklin Resources
Dimensional Fund Advisors
Samlyn Capital
Millennium Management
Bank of New York Mellon
Thompson, Siegel, & Walmsley
Avidity Partners Management

View all funds holding Jazz Pharmaceuticals